NCBI PubMed Centralopen access
Quality by design-based development of ibrutinib polymer-lipid hybrid nanoparticles for enhanced lymphatic absorption and anticancer efficacy.
computer science education
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Record · ID 362322
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.